RYAH Group (XCNQ:RYAH) Momentum Rank : 0 (As of Jun. 13, 2024)

View and export this data going back to 2021. Start your Free Trial

What is RYAH Group Momentum Rank?

RYAH Group has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

RYAH Group Momentum Rank Related Terms

Thank you for viewing the detailed overview of RYAH Group's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

RYAH Group (XCNQ:RYAH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RYAH Group Inc (XCNQ:RYAH) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232

Website

https://www.ryahgroup.com

RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.

RYAH Group (XCNQ:RYAH) Headlines

No Headlines